Sleep Aids (Pharmacies) - Sri Lanka

Revenue in the Sleep Aids market is projected to reach US$0.00 in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of NaN%, resulting in a market volume of US$0.00 by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$0.00 are generated in 2024.

Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.

Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Single Active Ingredient Formulations
Combination Active Ingredient Formulations
Herbal Remedies
Melatonin Products

Prescription Sleep Medications
Products for Chronic Insomnia which are not designed to address only occasional sleep challenges

The Sleep Aids (Pharmacies) market in Sri Lanka has been experiencing significant growth in recent years.

Customer preferences: Customers in Sri Lanka are increasingly seeking sleep aids to help them overcome sleep disorders and improve their overall sleep quality. This growing demand can be attributed to several factors. Firstly, the hectic and fast-paced lifestyle of modern society has led to an increase in stress levels, which often results in sleep disturbances. Additionally, the rising prevalence of chronic diseases such as diabetes and hypertension has also contributed to the demand for sleep aids, as these conditions can often disrupt sleep patterns.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Sri Lanka is the increasing popularity of natural and herbal sleep aids. Customers are becoming more conscious about the potential side effects of synthetic sleep aids and are seeking safer alternatives. As a result, there has been a surge in the demand for herbal supplements and remedies that promote sleep. This trend is in line with the global shift towards natural and organic products in the healthcare industry. Another trend in the market is the growing availability of sleep aids in pharmacies across the country. Pharmacies have recognized the increasing demand for sleep aids and have expanded their product offerings to cater to this need. This has made sleep aids more accessible to customers, leading to a higher adoption rate.

Local special circumstances: Sri Lanka has a high prevalence of sleep disorders, which has further fueled the growth of the Sleep Aids (Pharmacies) market. Factors such as irregular working hours, excessive use of electronic devices, and poor sleep hygiene contribute to the high incidence of sleep disorders in the country. As a result, there is a strong demand for effective sleep aids to help individuals overcome these issues and achieve a good night's sleep.

Underlying macroeconomic factors: The growing Sleep Aids (Pharmacies) market in Sri Lanka can also be attributed to favorable macroeconomic factors. The country has experienced steady economic growth in recent years, leading to an increase in disposable income. As a result, individuals are more willing to spend on healthcare products, including sleep aids. Furthermore, the government's focus on improving healthcare infrastructure and increasing access to healthcare services has also contributed to the growth of the market. In conclusion, the Sleep Aids (Pharmacies) market in Sri Lanka is witnessing significant growth due to increasing customer preferences for sleep aids, the availability of natural and herbal options, and the high prevalence of sleep disorders in the country. These trends, coupled with favorable macroeconomic factors, have created a conducive environment for the growth of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.